Stay updated with breaking news from Expanded Access Protocol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HUTCHMED (China) Limited (“HUTCHMED” or the “Company”) (Nasdaq/AIM:HCM; HKEX:13) announced that the U.S. Food and Drug Administration (“FDA” or the “Agency”) has issued a Complete Response Letter (“CRL”) regarding the New Drug Application (“NDA”) for surufatinib for the treatment of pancreatic (“pNETs”) and ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
/PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), today announced that 13 abstracts, including two oral presentations, will be...
EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Miscellaneous Relief Reports US Collaboration Partner Announces Expansion of Aviptadil US Expanded Access & Right to Try Programs for Patients
/PRNewswire/ -- FinancialNewsMedia.com News Commentary - Alzheimer's disease (AD) is the most common reason of progressive dementia in the elderly population....